# The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine

> **NCT05301920** · NA · COMPLETED · sponsor: **Nu Eyne Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Elexir (trigeminal nerve electrical stimulator)

## Key facts

- **NCT ID:** NCT05301920
- **Lead sponsor:** Nu Eyne Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-08
- **Primary completion:** 2022-01-28
- **Final completion:** 2022-01-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05301920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05301920, "The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05301920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*